Amsterdam, North Holland, Netherlands
Results-oriented biotech and pharma executive with demonstrated success discovering and developing new therapeutic technologies. I’ve dedicated my professional focus towards developing novel approaches to treat cancer and autoimmune disorders.
Leveraging extensive biotech and pharma industry know-how, founded an innovative organization committed to developing a new class of immune modulatory bio-therapeutics for treating autoimmunity and cancer. Serving as founding CEO, directed all activities related to licensing of foundational IP, guiding discovery and development processes to bring novel biotherapeutics to clinic. • Led the development of two first-in-class biotherapeutic antibodies, guiding research and development from initial target validation to antibody discovery and IND enabling studies • Guided funding activities, raising over $50M in venture capital funding and non-dilutive grants • Directed global operations for a semi-virtual organizational model
Managed a portfolio of pre-clinical immuno-oncology programs, ensuring a rapid path from initial research to clinic. Guided program teams from ideation to IND. • Created project plans and timelines to guide technical teams through lead identification, lead optimization, and pre-clinical development. • Developed project budgets, strategically justifying expenditures and ensuring adherence to established financials. • Managed the activities of external vendors and CROs, negotiating key contracts and performing due diligence to protect organizational interests.